An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy

DSpace/Manakin Repository

An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy

Citable link to this page

 

 
Title: An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy
Author: Klein, Oliver J.; Yuan, Hushan; Nowell, Nicholas H.; Kaittanis, Charalambos; Josephson, Lee; Evans, Conor L.

Note: Order does not necessarily reflect citation order of authors.

Citation: Klein, Oliver J., Hushan Yuan, Nicholas H. Nowell, Charalambos Kaittanis, Lee Josephson, and Conor L. Evans. 2017. “An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy.” Scientific Reports 7 (1): 13375. doi:10.1038/s41598-017-13803-4. http://dx.doi.org/10.1038/s41598-017-13803-4.
Full Text & Related Files:
Abstract: Targeted antineoplastic agents show great promise in the treatment of cancer, having the ability to impart cytotoxicity only to specific tumor types. However, these therapies do not experience uniform uptake throughout tumors, leading to sub-lethal cell killing that can impart treatment resistance, and cause problematic off-target effects. Here we demonstrate a photodynamic therapy construct that integrates both a cyclic RGD moiety for integrin-targeting, as well as a 5 kDa PEG chain that passivates the construct and enables its rapid diffusion throughout tumors. PEGylation of the photosensitizer construct was found to prevent photosensitizer aggregation, boost the generation of cytotoxic reactive radical species, and enable the rapid uptake of the construct into cells throughout large (>500 µm diameter) 3D tumor spheroids. Replacing the cyclic RGD with the generic RAD peptide led to the loss of cellular uptake in 3D culture, demonstrating the specificity of the construct. Photodynamic therapy with the construct was successful in inducing cytotoxicity, which could be competitively blocked by a tenfold concentration of free cyclic RGD. This construct is a first-of-its kind theranostic that may serve as a new approach in our growing therapeutic toolbox.
Published Version: doi:10.1038/s41598-017-13803-4
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645319/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492293
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters